Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy Associated With Dopaminergic Metabolism Deficit. A Randomized, Double Blind, Controlled Trial.

NCT00228371 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT00228371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00228371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy Associated With Dopaminergic Metabolism Deficit. A Randomized, Double Blind, Controlled Trial.
Lead sponsor
University Hospital, Grenoble
Phase
Phase 2/3
Overall status
Terminated
Start date
September 30, 2005
Completion date
March 31, 2010
Enrollment
4 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

drug resistant, epilepsy